Drug intelligence / Profile preview

Oxycort A

Development stage
Unknown
Lead developer
Valeant Pharmaceuticals
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Oxycort A is a topical ophthalmic and otic ointment that combines the tetracycline-class antibiotic oxytetracycline (as oxytetracycline hydrochloride) with the low‑potency glucocorticoid hydrocortisone acetate for local treatment of inflammatory conditions of the eye and, when prescribed by an ENT specialist, the external ear that are complicated by susceptible bacterial infection. Oxytetracycline exerts a bacteriostatic effect by binding the 30S ribosomal subunit and inhibiting bacterial protein synthesis in a broad range of Gram‑positive, Gram‑negative, and atypical organisms, while hydrocortisone acetate provides local anti‑inflammatory, anti‑edematous, and antipruritic effects through glucocorticoid receptor–mediated suppression of phospholipase A2 and pro‑inflammatory mediators.[1][13] This combination allows simultaneous control of infection and inflammation at ocular or external auditory sites, but prolonged use can increase intraocular pressure and risk of glaucoma, optic nerve damage, and posterior subcapsular cataract, necessitating short treatment courses and monitoring when used around the eye.[1]

Brand names
Oxycort A
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Oxycort A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxycort A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call